What you'll learn:
- What the amylase blood test actually measures.
- Normal, elevated, and low amylase reference ranges.
- What causes high and low amylase, and which conditions each pattern points to.
- Why amylase is tested alongside lipase, and what that combination reveals.
- When to retest and which other markers to check at the same time.
What Is the Amylase Blood Test?
The amylase blood test (also called serum amylase) measures the concentration of amylase enzyme circulating in your bloodstream. Under normal conditions, small amounts of amylase are present in blood as part of routine turnover. When levels rise significantly above baseline, it indicates that the pancreas or salivary glands are releasing excess amylase, usually as a result of inflammation, obstruction, or tissue damage.
You may see this test ordered as:
- Serum amylase
- Blood amylase
- Pancreatic amylase (when the lab differentiates pancreatic vs. salivary origin)
- Amylase and lipase panel (the most common combination)
Amylase alone is useful but limited. Lipase is considered more specific to pancreatic injury, which is why the two are almost always interpreted together when pancreatitis is suspected.
Low Amylase and Pancreatic Insufficiency
Low amylase, typically below 30 U/L, is less discussed than high amylase but clinically meaningful. It usually reflects reduced production rather than excess release — the pancreas has lost enough functional tissue that it can no longer produce normal enzyme volumes.
Exocrine pancreatic insufficiency (EPI) is the most common cause. In EPI, the pancreatic acinar cells responsible for enzyme production are progressively damaged or replaced by scar tissue. The result is impaired digestion, particularly of fats and complex carbohydrates.
Conditions associated with low amylase include:
Chronic pancreatitis. Repeated episodes of inflammation cause cumulative scarring. As functional tissue is replaced by fibrotic tissue, amylase output falls. Paradoxically, amylase may be normal or even elevated during acute flares but low during stable periods in advanced disease.
Cystic fibrosis. CF causes thick mucus to block pancreatic ducts, impairing enzyme secretion. Pancreatic insufficiency affects around 85% of people with CF.
Post-surgical pancreatic changes. Partial pancreatectomy or Whipple procedure reduces the amount of enzyme-producing tissue. Low amylase is expected and monitored post-operatively.
Advanced liver disease. Severe hepatic dysfunction can reduce amylase production, as the liver plays a supporting role in overall enzyme metabolism.
Symptoms that may accompany low amylase:
- Steatorrhea — pale, greasy, foul-smelling stools caused by fat malabsorption
- Unintentional weight loss
- Bloating or cramping after eating, particularly after high-fat meals
- Nutritional deficiencies, including fat-soluble vitamins A, D, E, and K
Low amylase is most meaningful when interpreted alongside lipase, fecal elastase (a more sensitive marker of EPI), and nutritional markers. A single low amylase result without symptoms or context is not diagnostic on its own.
Retesting if amylase is low: If low amylase is incidental and you have no symptoms, retest in 6 to 8 weeks alongside lipase. If low amylase is paired with GI symptoms or unexplained weight loss, a fecal elastase test is the appropriate next step and worth discussing with a clinician.
Research published in Clinical Chemistry supports lipase as the preferred single marker for diagnosing acute pancreatitis, with amylase adding value primarily in the early window or when salivary gland involvement needs to be ruled out. Most clinicians order both.
How the Pancreas and Liver Connect
The pancreas and liver share anatomy and function in ways that make it useful to assess both when either is under stress. The common bile duct and pancreatic duct merge before entering the small intestine at the ampulla of Vater. Gallstones blocking this junction cause pancreatitis and liver enzyme elevations simultaneously. Fatty liver disease is associated with higher rates of non-alcoholic fatty pancreas disease, which can manifest as chronic low-grade amylase and lipase elevations.
For this reason, a full picture of digestive and metabolic health usually includes both liver enzymes (ALT, AST, GGT) and pancreatic enzymes (amylase, lipase), particularly in people who drink regularly, are on GLP-1 medications, or have metabolic syndrome.
People with insulin resistance or fatty liver are at higher baseline risk for pancreatic stress, making combined testing more valuable than either panel alone.
Symptoms That Often Accompany Abnormal Amylase
Elevated amylase is not always symptomatic, particularly with mild elevations. When symptoms are present alongside high amylase, they commonly include:
- Upper abdominal pain, especially after eating fatty meals.
- Nausea or vomiting.
- Pain that radiates to the back.
- Fever in cases of acute pancreatitis.
Seek emergency care if you experience severe, sudden upper abdominal pain, especially with vomiting, as this can indicate acute pancreatitis requiring immediate evaluation.
When to Retest Amylase
Retest timing depends on the context:
- Acute elevation (suspected pancreatitis): Serial testing every 24-48 hours until resolution is standard clinical practice.
- Mild, unexplained elevation: Retest in 4-8 weeks after removing potential causes (alcohol, high-fat diet, recent illness).
- On GLP-1 medications: Baseline before starting, then at 3 and 6 months. Amylase and lipase are two of several markers worth tracking — for the full picture of what to test and when, see our GLP-1 blood test monitoring checklist.
- Chronic pancreatitis monitoring: Every 3-6 months alongside lipase and liver enzymes.
Conclusion
Amylase is a direct measure of how the pancreas and salivary glands are functioning. Elevated results usually point to pancreatic inflammation, gallbladder involvement, or salivary gland issues, while low results suggest reduced pancreatic output. It is most useful when interpreted alongside lipase, liver enzymes, and metabolic markers rather than in isolation.
